Thalassemia Market, By Type (Alpha Thalassemia, Beta Thalassemia, Delta Thalassemia, and Combination Thalassemia (Mixed Type)), By Treatment Type (Blood Transfusion Therapy, Iron Chelation Therapy, Stem Cell Transplantation, Gene Therapy, Pharmacotherapy (e.g., Hydroxyurea, Luspatercept), and Others (Supportive Care)), By End User (Hospitals and Clinics, Diagnostic Laboratories, Research and Academic Institutions, and Specialty Treatment Centers), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Age Group (Adult, Pediatric, and Geriatric), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)